Abstract

The invention relates to methods, reagents and kits for detecting the susceptibility to cervical cancer. In particular, it relates to novel methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3 (CIN2/3) and the use thereof for identifying a cervical cell as neoplastic or predisposed to neoplasia in an isolated sample.
Original languageEnglish
Patent numberWO2016048138
Priority date22/09/2014
Publication statusPublished - 31-Mar-2016

Cite this